Tsiantoulas et al. [24] studied Apoe−/− and Ldlr−/− mice and found that anti-BAFF antibody treatment could deplete CD19(+)CD5(−) B cells and increased atherosclerosis. This evidence concerns the gene TNFSF13B and atherosclerosis.